USC scientists just unlocked an endless supply of cancer-fighting immune cells
USC scientists have developed a new technique to enable the continuous self-renewal of immune cells used in cancer-fighting therapy.
The story so far
Researchers at the University of Southern California (USC) report a breakthrough in the production of progenitor cells. The new method allows these cells to self-renew in a laboratory environment, effectively addressing previous supply limitations in macrophage therapy.
Coverage from Tech Explorist, Tech Times, ThePrint, and ScienceDaily highlights this development as a potential solution to scaling immune cell production. Reports emphasize the capability of these cells to replicate indefinitely while maintaining their therapeutic properties.
Future developments will depend on the scalability of this lab-based technique. Coverage does not yet specify a timeline for clinical implementation or transition to human trials.
Synthesized by headlinez.news from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 53d ago.
The reporting (5)
- USC Engineers Unlimited Supply of Cancer-Fighting Macrophages From Bone Marrow Tech Times · 55d ago
- A new technique could keep cancer-fighting cells coming Tech Explorist · 55d ago
- Progenitor Cells Self-Renew in Lab, Breaking Macrophage Therapy Supply Barrier Tech Times · 55d ago
- Scientists at USC have figured out how to create an army of cells to fight cancer ThePrint · 55d ago
- USC scientists just unlocked an endless supply of cancer-fighting immune cells ScienceDaily · 55d ago
The obvious questions
What have USC scientists achieved?
They have developed a technique to generate an endless supply of cancer-fighting immune cells through progenitor cell self-renewal.
Why is this significant for cancer treatment?
It removes a supply barrier for macrophage therapy, allowing for the potential production of large quantities of therapeutic cells.
Are human trials currently underway?
Coverage does not yet specify whether human trials have been scheduled or initiated.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Topics
Related trends
Scientists Can Now Spot Alzheimer’s 10 Years Before Symptoms
Diagnostic advancements in blood-based testing are shifting the Alzheimer's detection timeline, enabling the identification of risks years before symptoms.
CRISPR makes prostate cancer vulnerable to immunotherapy
CRISPR editing turns immune‑cold prostate tumors into immunotherapy targets, sparking a new treatment direction.
Doctors Say This Everyday Drink Could Cut Liver Cancer Risk by Nearly 50%, New Study Finds
New research findings on July 25, 2026, suggest a potential link between increased coffee consumption and a reduced risk of liver cancer.
Scientists find compound that may help muscles stay strong as we age
Researchers have identified a novel molecule that shows potential in reversing or slowing age-related muscle decline.
Breathalyser can tell if you are burning fat from a single exhalation
New sensor technology allows users to detect when their body shifts into fat-burning mode through a single exhalation.
Engineered enzyme erases a stubborn mark of aging by up to 70% in human tissue samples
Researchers have engineered an enzyme capable of reversing a chemical marker of aging in human tissue samples by as much as 70%.